T. Pross

Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients.

R. Roehle, F. Fischer, M. Karsten, 2022, European journal of cancer.

Examining the Feasibility of an Application-Based Patient-Reported Outcome Monitoring for Breast Cancer Patients: A Pretest for the PRO B Study

U. Grittner, M. Karsten, F. Kühn, 2022, International journal of environmental research and public health.

How VEGF-A and its splice variants affect breast cancer development – clinical implications

C. Denkert, P. Jank, M. Karsten, 2022, Cellular Oncology.

PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial

U. Grittner, C. Kowalski, F. Fischer, 2021, Trials.

Lymphatic micrometastases predict biochemical recurrence in patients undergoing radical prostatectomy and pelvic lymph node dissection for prostate cancer

C. Stephan, K. Jung, K. Miller, 2018, Aktuelle Urologie.

Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)

M. Karsten, D. Speiser, T. Pross, 2021, Geburtshilfe und Frauenheilkunde.